Thyroid disease, both thyrotoxicosis and hypothyroidism, are associated with adverse pregnancy outcomes and poor fetal development, including neurocognitive outcomes. Given the importance of understanding physiology, changes during pregnancy, and management, ACOG has published recommendations to guide clinical decision-making. Universal TSH screening for thyroid disease in pregnancy is not recommended. Subclinical thyroid disease (abnormal TSH but normal free T4) does not require treatment. However, overt hyperthyroidism and hypothyroidism warrant further management
Low TSH and Increased free T4
Note: Maternal antibodies found in Graves disease cross the placenta and are cleared slowly | Notify neonatology of maternal diagnosis as neonatal Graves disease may not present immediately following delivery
High TSH, Low Free T4
Get Guideline Alerts Direct to Your Phone
Please log in to ObGFirst to access the 2T US Atlas
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst
You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site